Carduso Capital invests in PIMS-E, a Spin-off company of the University of Groningen that aims to develop an epinephrine dry powder inhaler as alternative to Epipen™.
Menu
Recent Posts
Categories
Categories
- Press release (9)
- Publication (2)
- Scientific publication (4)
- Status update (2)